Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ivan Roberto Lolli"'
Autor:
Rosalba D’Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, Giampiero De Leonardis, Rossella Donghia, Vito Guerra, Gianluigi Giannelli, Ivan Roberto Lolli, Maria Maddalena Laterza, Ferdinando De Vita, Caterina Messa, Claudio Lotesoriere
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/bdbbe366da69448e959e5d710e22e3fb
Autor:
Rosalba D’Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, Giampiero De Leonardis, Rossella Donghia, Vito Guerra, Gianluigi Giannelli, Ivan Roberto Lolli, Maria Maddalena Laterza, Ferdinando De Vita, Caterina Messa, Claudio Lotesoriere
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The combination of paclitaxel and ramucirumab is the second-line therapy of choice in the treatment of advanced gastric cancer. To date, no biomarkers are available in gastric cancer to predict the outcome of antiangiogenic therapy. The present prosp
Externí odkaz:
https://doaj.org/article/3efbf49ad686441bbde8303cc2189b7f
Autor:
Angela Dalia Ricci, Rosalba D'Alessandro, Alessandro Rizzo, Annalisa Schirizzi, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Claudio Lotesoriere, Gianluigi Giannelli
Publikováno v:
Immunotherapy. 15:477-486
Following the practice-changing results observed in several hematological and solid tumors, immunotherapy with immune checkpoint inhibitors (ICIs) has been tested in cholangiocarcinoma (CCA) patients. However, ICI monotherapy has had disappointing re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b34c4b2bd8daf3616505a62fd45aa3d2
https://doi.org/10.2217/imt-2022-0301
https://doi.org/10.2217/imt-2022-0301
Autor:
Annalisa Schirizzi, Giampiero De Leonardis, Vincenza Lorusso, Rossella Donghia, Alessandro Rizzo, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Gianluigi Giannelli, Angela Dalia Ricci, Rosalba D’Alessandro, Claudio Lotesoriere
Publikováno v:
Cancers. 15:2376
Although biliary tract cancers are traditionally considered rare in Western countries, their incidence and mortality rates are rising worldwide. A better knowledge of the genomic landscape of these tumor types has broadened the number of molecular ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::856fb964909d6479262a1891de8048c3
https://doi.org/10.3390/cancers15082376
https://doi.org/10.3390/cancers15082376